Perrin Megan Wilson - 17 Jun 2025 Form 3 Insider Report for Climb Bio, Inc. (CLYM)

Role
Chief Business Officer
Signature
/s/ Chandra Adams, as Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
3
Filing time
23 Jun 2025, 16:15:07 UTC
Next filing
08 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wilson Perrin Megan Chief Business Officer C/O CLIMB BIO, INC., 20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS /s/ Chandra Adams, as Attorney-in-Fact 23 Jun 2025 0002074091

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLYM Stock Option (Right to Buy) 17 Jun 2025 Common Stock 600,000 $1.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 10, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through February 10, 2029, subject to the Reporting Person's continued service.

Remarks:

Exhibit Index: 24.1 - Power of Attorney